EVgo enters the post-earnings week looking more complicated than the headline print suggests.
Q1 revenue of $109.5 million beat estimates by a wide margin — more than $21 million ahead. The EPS miss was just one cent. Full-year guidance of $410–$470 million was reaffirmed. On the surface, a constructive result. The problem is Q2: management guided $75–85 million in sales against a Street consensus of around $106 million. That gap is what's driving the action — and what's keeping short sellers parked.
Short positioning tells a story of deep, sticky conviction. SI held near 34.7% of the free float as of May 5 — virtually unchanged on the week despite the Q1 beat, and up sharply from roughly 30% at the start of April. Days to cover run close to nine on FINRA's latest fortnightly print of 46.4 million shares. That's not a light hedge or a tactical position; that's a structural short thesis that a single revenue beat didn't dislodge. The ORTEX short score has climbed to 80.3 — near its highest reading of the past month — reflecting both the volume of shorts and the momentum behind the position.
Borrow conditions complicate the short thesis, but not dramatically. The cost to borrow has more than doubled over the past month, moving from around 0.60% in late March to 1.19% now. That's still cheap in absolute terms — far below the level at which borrow costs become a meaningful squeeze catalyst. Availability is around 57% of outstanding short interest, which counts as tight-to-normal. It has been as low as 42% in late March and briefly touched 59% — roughly the 52-week high — in late April. There's no borrow squeeze underway, but the lending pool is not getting looser. Options lean call-heavy, with a put/call ratio of 0.21 — in line with its 20-day average of 0.21 and nowhere near defensive territory. That PCR sits close to the 52-week low of 0.18, meaning options traders are positioned for upside, not protection. The contrast with the scale of short positioning is notable.
The Street is divided but leaning cautious. RBC Capital maintained its Outperform rating today but cut its target from $4.50 to $3.00 — directly citing the weaker Q2 outlook. Cantor Fitzgerald also trimmed its target following the print. That continues a pattern of target cuts that dates to early March, when multiple firms including RBC and Evercore ISI shaved estimates. JP Morgan downgraded to Neutral in late March. The mean analyst target is now $4.25, implying more than 100% upside to the current $2.10 price — but that figure reflects targets set before today's Q2 guidance shock and will likely drift lower as the week closes. The bull case rests on 25% year-over-year throughput growth and an EBITDA breakeven target for Q4 2025 (now a 2030 target of $0.5 billion per updated company guidance). The bear case is simpler: a sequential revenue decline in Q2 of roughly 25-30% implied by the new guidance range, arriving in a market already sceptical of EV demand.
Institutional holders provide a passive backdrop, with Vanguard, BlackRock, and State Street holding the top three positions. Blackrock added 261,748 shares as recently as April 30. State Street made a notably larger addition — over 2.3 million shares — in the same filing period. Insider activity was modest in March, with CEO Badar Khan and President Dennis Kish both selling small amounts in conjunction with routine equity awards. Net insider activity over the past 90 days is marginally positive on a share count basis, though values are negligible relative to the stock's market cap of roughly $305 million.
The next confirmed event is an earnings call on May 14. Between now and then, the tension to watch is whether Q2 guidance causes additional analyst target reductions that compress the mean target toward the current price — and whether short interest, already at multi-month highs, absorbs or responds to any further deterioration in the forward outlook.
See the live data behind this article on ORTEX.
Open EVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
